世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
メタボリック検査に関する市場調査。世界市場：北米がリードし、アジア地域がこれに次ぐMarket Study on Metabolic Testing: Global Market Led by North America, Followed by Asian Region メタボリックテストの市場レポート範囲 Persistence Market Researchが発行する世界の代謝検査市場に関する最新市場レポートは、機会や現在の市場シナリオを評価し、2022年から2032年の予測期間において市場に... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーメタボリックテストの市場レポート範囲Persistence Market Researchが発行する世界の代謝検査市場に関する最新市場レポートは、機会や現在の市場シナリオを評価し、2022年から2032年の予測期間において市場に関与する対応するセグメントに関する洞察や最新情報を提供します。主要な市場力学の詳細な評価と、市場構造に関する包括的な情報を提供しています。2022-2032年の予測期間中に市場がどのように成長すると予想されるかについての詳細な洞察が含まれています。 本レポートの主な目的は、代謝検査に関連するグローバルビジネスの変革を支えている市場の機会に関する洞察を提供することです。常に変動する経済において、読者が市場の分析と評価をより良く理解し、この空間における有利な機会を発見できるように、全体的な予測のための複合年間成長率（CAGR）に加えて、推定（Y-oY）対前年成長率を提供することを考慮することは非常に重要である。 また、本レポートでは、市場規模の推定とそれに対応する絶対額での収益予測も行っています。また、市場の将来的な動向に基づいた実用的な洞察も提供しています。さらに、世界の代謝検査市場における新規および新興のプレーヤーは、効果的なビジネス上の意思決定のために本調査で提示された情報を利用することができ、世界市場だけでなく、そのビジネスにも勢いを与えることになるでしょう。 この研究は、代謝検査市場のメーカー、サプライヤー、流通業者、投資家に関連するものである。すべての利害関係者、業界専門家、研究者、ジャーナリスト、ビジネス研究者は、本レポートに表された情報とデータを活用することができます。 主要な市場セグメント Persistence Market Research社の調査レポートでは、代謝検査の世界市場について、製品、用途、技術、エンドユーザー、地域の5つのセグメントに分けて情報を提供しています。 製品 CPETシステム メタボリックカート 体内消費量測定器 心電計・心電計（CPETシステム装着用 ソフトウェア アプリケーション 生活習慣病 クリティカルケア ヒューマンパフォーマンステスティング メタボリックシンドロームX 代謝異常 その他のアプリケーション 技術情報 VO2マックス解析 RMR解析 体組成分析 エンドユーザー 病院 ラボラトリー スポーツトレーニングセンター スポーツジム その他のエンドユーザー 地域別 北アメリカ 欧州 中南米 東アジア 中近東・アフリカ 南アジア・太平洋地域 本調査で回答した主な質問 予測期間中に最も高い市場シェアを占めるのはどの地域か？ 最も高い成長（CAGR）を遂げているのはどの地域か？ 世界のメタボリックテスト産業に影響を与えている要因は何か？ 市場に影響を及ぼしている世界的なトレンドは何か？ 市場の様々な地域における機会を捉えるために、新興プレイヤーはどのような戦略を採用しなければならないか？ 世界のメタボリックテスト市場の構造とは？ 調査方法 Persistence Market Research社は、偏りのない市場調査ソリューションを顧客に提供することに取り組んでいます。同社は、本レポートに含まれるデータの控除について、堅牢な方法論に従っています。世界の代謝検査市場に関する広範な調査を実施し、市場の将来の成長要因に関する結論に到達するために、独自の調査手法を活用しています。調査手法は、一次調査手法と二次調査手法の組み合わせで構成されており、本レポートの結論の正確性と信頼性を保証しています。 需要サイドのアプローチで対象製品の売上高を推定し、次に供給サイドのアプローチであらかじめ定義された期間における生成価値、主要トレンド、イベントに関する詳細な評価を行います。 この手法は、Persistence Market Researchが世界市場のセグメント化のために考慮する、北米、中南米、ヨーロッパ、南アジア・太平洋、東アジア、中東・アフリカの6地域以上の現地ソースからのインプットに基づく、標準の市場構造、手法、定義に基づいています。統計、特性、差異を地域レベルで収集し、同じレベルで集計し、世界レベルで統合して、世界市場の測定値を作成しています。 主な調査対象は以下の通りです。 プライマリーリサーチ セカンダリーリサーチ 貿易調査 ソーシャルメディアリサーチ 目次1. Executive Summary1.1. Global Market Overview 1.2. Summary of Key Statistics 1.3. Summary of Key Findings 1.4. Product Evolution Analysis 1.5. PMR Analysis and Recommendations 2. Market Overview 2.1. Market Coverage/Taxonomy 2.2. Market Definition/Scope/Limitations 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Future Prospects of Metabolic Testing Industry 3.2.1. Factors Fuelling Growth 3.2.2. Influx of Brands 3.2.3. Innovative Distribution & Marketing Strategies 4. Rules and Regulations 4.1. Warning Labels 4.2. Regulatory Options for Little Cigars 4.2.1. Product Description 4.2.2. Health Risks 4.2.3. End Usering 4.2.4. Minimum Pack Technology Regulatory Gap 4.3. Cigar Labeling and Warning Statement Requirements by FDA 4.4. Tobacco Control Laws 4.4.1. Use of E-Cigarettes is Prohibited 4.4.2. Tobacco Advertising is Prohibited in Mass Media 4.4.3. Others 4.5. Others (During the Course of Study) 5. Global Metabolic Testing Market Demand Analysis 2017-2021 and Forecast, 2022-2032 5.1. Historical Market Volume ('000 Units) Analysis, 2017-2021 5.2. Current and Future Market Volume ('000 Units) Projections, 2022-2032 5.3. Y-o-Y Growth Trend Analysis 6. Global Metabolic Testing Market - Pricing Analysis 6.1. Pricing Analysis By Product 6.2. Global Average Pricing Analysis Benchmark 7. Global Metabolic Testing Market Demand (in Value or Technology in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032 7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Market Background 8.1. Global Cigar industry Outlook 8.1.1. Perception of Cigars 8.1.2. Prevalence of Smoking Cigars among Adults 8.1.3. Top 10 Cigars & Cigarillo Companies in the World 8.2. Macro-Economic Factors 8.2.1. GDP Growth Outlook 8.2.2. Consumer Spending Outlook 8.2.3. GDP Growth Rate Analysis 8.2.4. Income Group Population Overview 8.2.5. Per Capita Disposable Income 8.3. Forecast Factors - Relevance & Impact 8.3.1. Top Companies Historical Growth 8.3.2. Urbanization Growth Outlook 8.3.3. Others 8.4. PESTLE Analysis of Global Metabolic Testing Market 8.5. Investment Feasibility Matrix of Metabolic Testing Market 8.6. Porter’s Five Forces Analysis of Global Metabolic Testing Market 8.7. Market Dynamics 8.7.1. Drivers 8.7.2. Restraints 8.7.3. Opportunity Analysis 9. Global Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Product 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis by Product, 2017 - 2021 9.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Product, 2022 - 2032 9.3.1. CPET Systems 9.3.2. Metabolic Carts 9.3.3. Body Consumption Analyzers 9.3.4. ECGs/EKGs Attachable to CPET Systems 9.3.5. Software 9.4. Market Attractiveness Analysis by Product 10. Global Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Application 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis by Application, 2017 - 2021 10.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Application, 2022 - 2032 10.3.1. Lifestyle Diseases 10.3.2. Critical Care 10.3.3. Human Performance Testing 10.3.4. Dysmetabolic Syndrome X 10.3.5. Metabolic Disorders 10.3.6. Other Applications 10.4. Market Attractiveness Analysis by Application 11. Global Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Technology 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis by Technology, 2017 - 2021 11.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Technology, 2022 - 2032 11.3.1. VO2 Max Analysis 11.3.2. RMR Analysis 11.3.3. Body Composition Analysis 11.4. Market Attractiveness Analysis by Technology 12. Global Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032, by End User 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis by Flavor, 2017 - 2021 12.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Flavor, 2022 - 2032 12.3.1. Hospitals 12.3.2. Laboratories 12.3.3. Sports Training Centers 12.3.4. Gyms 12.3.5. Other End Users 12.4. Market Attractiveness Analysis by Flavor 13. Global Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Region 13.1. Introduction 13.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis by Region, 2017 - 2021 13.3. Current Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Region, 2022 - 2032 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. East Asia 13.3.5. South Asia 13.3.6. Oceania 13.3.7. Middle East and Africa (MEA) 13.4. Market Attractiveness Analysis by Region 14. North America Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021 14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032 14.4.1. By Country 14.4.1.1. U.S. 14.4.1.2. Canada 14.4.2. By Product 14.4.3. By End User 14.4.4. By Application 14.4.5. By Technology 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Product 14.5.3. By End User 14.5.4. By Application 14.5.5. By Technology 15. Latin America Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021 15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032 15.4.1. By Country 15.4.1.1. Brazil 15.4.1.2. Mexico 15.4.1.3. Rest of Latin America 15.4.2. By Product 15.4.3. By End User 15.4.4. By Application 15.4.5. By Technology 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Product 15.5.3. By End User 15.5.4. By Application 15.5.5. By Technology 16. Europe Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021 16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032 16.4.1. By Country 16.4.1.1. Germany 16.4.1.2. Italy 16.4.1.3. France 16.4.1.4. U.K. 16.4.1.5. Spain 16.4.1.6. Rest of Europe 16.4.2. By Product 16.4.3. By End User 16.4.4. By Application 16.4.5. By Technology 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Product 16.5.3. By End User 16.5.4. By Application 16.5.5. By Technology 17. South Asia Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032 17.1. Introduction 17.2. Pricing Analysis 17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021 17.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032 17.4.1. By Country 17.4.1.1. India 17.4.1.2. Thailand 17.4.1.3. Indonesia 17.4.1.4. Malaysia 17.4.1.5. Rest of South Asia 17.4.2. By Product 17.4.3. By End User 17.4.4. By Application 17.4.5. By Technology 17.5. Market Attractiveness Analysis 17.5.1. By Country 17.5.2. By Product 17.5.3. By End User 17.5.4. By Application 17.5.5. By Technology 18. East Asia Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032 18.1. Introduction 18.2. Pricing Analysis 18.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021 18.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032 18.4.1. By Country 18.4.1.1. China 18.4.1.2. Japan 18.4.1.3. South Korea 18.4.2. By Product 18.4.3. By End User 18.4.4. By Application 18.4.5. By Technology 18.5. Market Attractiveness Analysis 18.5.1. By Country 18.5.2. By Product 18.5.3. By End User 18.5.4. By Application 18.5.5. By Technology 19. Oceania Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032 19.1. Introduction 19.2. Pricing Analysis 19.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021 19.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032 19.4.1. By Country 19.4.1.1. Australia 19.4.1.2. New Zealand 19.4.2. By Product 19.4.3. By End User 19.4.4. By Application 19.4.5. By Technology 19.5. Market Attractiveness Analysis 19.5.1. By Country 19.5.2. By Product 19.5.3. By End User 19.5.4. By Application 19.5.5. By Technology 20. Middle East and Africa Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032 20.1. Introduction 20.2. Pricing Analysis 20.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021 20.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032 20.4.1. By Country 20.4.1.1. GCC Countries 20.4.1.2. Northern Africa 20.4.1.3. South Africa 20.4.1.4. Rest of Middle East and Africa 20.4.2. By Product 20.4.3. By End User 20.4.4. By Application 20.4.5. By Technology 20.5. Market Attractiveness Analysis 20.5.1. By Country 20.5.2. By Product 20.5.3. By End User 20.5.4. By Application 20.5.5. By Technology 21. Key Countries’ Metabolic Testing Market Analysis 2022-2032 21.1. Introduction 21.1.1. Market Value Proportion Analysis, By Key Countries 21.1.2. Global Vs. Country Growth Comparison 21.2. U.S. Metabolic Testing Market Analysis 21.2.1. By Product 21.2.2. By End User 21.2.3. By Application 21.2.4. By Technology 21.3. Canada Metabolic Testing Market Analysis 21.3.1. By Product 21.3.2. By End User 21.3.3. By Application 21.3.4. By Technology 21.4. Mexico Metabolic Testing Market Analysis 21.4.1. By Product 21.4.2. By End User 21.4.3. By Application 21.4.4. By Technology 21.5. Brazil Metabolic Testing Market Analysis 21.5.1. By Product 21.5.2. By End User 21.5.3. By Application 21.5.4. By Technology 21.6. Germany Metabolic Testing Market Analysis 21.6.1. By Product 21.6.2. By End User 21.6.3. By Application 21.6.4. By Technology 21.7. Italy Metabolic Testing Market Analysis 21.7.1. By Product 21.7.2. By End User 21.7.3. By Application 21.7.4. By Technology 21.8. U.K. Metabolic Testing Market Analysis 21.8.1. By Product 21.8.2. By End User 21.8.3. By Application 21.8.4. By Technology 21.9. China Metabolic Testing Market Analysis 21.9.1. By Product 21.9.2. By End User 21.9.3. By Application 21.9.4. By Technology 21.10. Japan Metabolic Testing Market Analysis 21.10.1. By Product 21.10.2. By End User 21.10.3. By Application 21.10.4. By Technology 21.11. S. Korea Metabolic Testing Market Analysis 21.11.1. By Product 21.11.2. By End User 21.11.3. By Application 21.11.4. By Technology 21.12. India Metabolic Testing Market Analysis 21.12.1. By Product 21.12.2. By End User 21.12.3. By Application 21.12.4. By Technology 21.13. Australia and New Zealand Metabolic Testing Market Analysis 21.13.1. By Product 21.13.2. By End User 21.13.3. By Application 21.13.4. By Technology 21.14. South Africa Metabolic Testing Market Analysis 21.14.1. By Product 21.14.2. By End User 21.14.3. By Application 21.14.4. By Technology 22. Market Structure Analysis 22.1. Market Analysis by Tier of Companies (Metabolic Testing) 22.2. Market Concentration 22.3. Market Share Analysis of Top Players 22.4. Market Presence Analysis 22.4.1. By Regional footprint of Players 22.4.2. Product foot print by Players 22.4.3. Channel Foot Print by Players 23. Competition Analysis 23.1. Competition Dashboard 23.2. Pricing Analysis by Competition 23.3. Competition Benchmarking 23.4. Competition Deep Dive 23.4.1. CareFusion Corporation 23.4.1.1. Overview 23.4.1.2. Product Portfolio 23.4.1.3. Profitability by Market Segments (Product/Channel/Region) 23.4.1.4. Sales Footprint 23.4.1.5. Strategy Overview 23.4.1.5.1. Marketing Strategy 23.4.1.5.2. Product Strategy 23.4.1.5.3. Channel Strategy 23.4.2. General Electric Company 23.4.2.1. Overview 23.4.2.2. Product Portfolio 23.4.2.3. Profitability by Market Segments (Product/Channel/Region) 23.4.2.4. Sales Footprint 23.4.2.5. Strategy Overview 23.4.2.5.1. Marketing Strategy 23.4.2.5.2. Product Strategy 23.4.2.5.3. Channel Strategy 23.4.3. Geratherm Medical AG 23.4.3.1. Overview 23.4.3.2. Product Portfolio 23.4.3.3. Profitability by Market Segments (Product/Channel/Region) 23.4.3.4. Sales Footprint 23.4.3.5. Strategy Overview 23.4.3.5.1. Marketing Strategy 23.4.3.5.2. Product Strategy 23.4.3.5.3. Channel Strategy 23.4.4. MGC Diagnostics Corporation 23.4.4.1. Overview 23.4.4.2. Product Portfolio 23.4.4.3. Profitability by Market Segments (Product/Channel/Region) 23.4.4.4. Sales Footprint 23.4.4.5. Strategy Overview 23.4.4.5.1. Marketing Strategy 23.4.4.5.2. Product Strategy 23.4.4.5.3. Channel Strategy 23.4.5. OSI Systems, Inc. 23.4.5.1. Overview 23.4.5.2. Product Portfolio 23.4.5.3. Profitability by Market Segments (Product/Channel/Region) 23.4.5.4. Sales Footprint 23.4.5.5. Strategy Overview 23.4.5.5.1. Marketing Strategy 23.4.5.5.2. Product Strategy 23.4.5.5.3. Channel Strategy 23.4.6. AEI Technologies, Inc. 23.4.6.1. Overview 23.4.6.2. Product Portfolio 23.4.6.3. Profitability by Market Segments (Product/Channel/Region) 23.4.6.4. Sales Footprint 23.4.6.5. Strategy Overview 23.4.6.5.1. Marketing Strategy 23.4.6.5.2. Product Strategy 23.4.6.5.3. Channel Strategy 23.4.7. Cortex Biophysik GmbH 23.4.7.1. Overview 23.4.7.2. Product Portfolio 23.4.7.3. Profitability by Market Segments (Product/Channel/Region) 23.4.7.4. Sales Footprint 23.4.7.5. Strategy Overview 23.4.7.5.1. Marketing Strategy 23.4.7.5.2. Product Strategy 23.4.7.5.3. Channel Strategy 23.4.8. COSMED 23.4.8.1. Overview 23.4.8.2. Product Portfolio 23.4.8.3. Profitability by Market Segments (Product/Channel/Region) 23.4.8.4. Sales Footprint 23.4.8.5. Strategy Overview 23.4.8.5.1. Marketing Strategy 23.4.8.5.2. Product Strategy 23.4.8.5.3. Channel Strategy 23.4.9. Korr Medical Technologies, Inc. 23.4.9.1. Overview 23.4.9.2. Product Portfolio 23.4.9.3. Profitability by Market Segments (Product/Channel/Region) 23.4.9.4. Sales Footprint 23.4.9.5. Strategy Overview 23.4.9.5.1. Marketing Strategy 23.4.9.5.2. Product Strategy 23.4.9.5.3. Channel Strategy 23.4.10. Microlife Medical Home Solutions, Inc. 23.4.10.1. Overview 23.4.10.2. Product Portfolio 23.4.10.3. Profitability by Market Segments (Product/Channel/Region) 23.4.10.4. Sales Footprint 23.4.10.5. Strategy Overview 23.4.10.5.1. Marketing Strategy 23.4.10.5.2. Product Strategy 23.4.10.5.3. Channel Strategy 23.4.11. Parvo Medics, Inc. 23.4.11.1. Overview 23.4.11.2. Product Portfolio 23.4.11.3. Profitability by Market Segments (Product/Channel/Region) 23.4.11.4. Sales Footprint 23.4.11.5. Strategy Overview 23.4.11.5.1. Marketing Strategy 23.4.11.5.2. Product Strategy 23.4.11.5.3. Channel Strategy 24. Assumptions and Acronyms Used 25. Research Methodology
SummaryMetabolic Testing Market: Report Scope Table of Contents1. Executive Summary1.1. Global Market Overview 1.2. Summary of Key Statistics 1.3. Summary of Key Findings 1.4. Product Evolution Analysis 1.5. PMR Analysis and Recommendations 2. Market Overview 2.1. Market Coverage/Taxonomy 2.2. Market Definition/Scope/Limitations 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Future Prospects of Metabolic Testing Industry 3.2.1. Factors Fuelling Growth 3.2.2. Influx of Brands 3.2.3. Innovative Distribution & Marketing Strategies 4. Rules and Regulations 4.1. Warning Labels 4.2. Regulatory Options for Little Cigars 4.2.1. Product Description 4.2.2. Health Risks 4.2.3. End Usering 4.2.4. Minimum Pack Technology Regulatory Gap 4.3. Cigar Labeling and Warning Statement Requirements by FDA 4.4. Tobacco Control Laws 4.4.1. Use of E-Cigarettes is Prohibited 4.4.2. Tobacco Advertising is Prohibited in Mass Media 4.4.3. Others 4.5. Others (During the Course of Study) 5. Global Metabolic Testing Market Demand Analysis 2017-2021 and Forecast, 2022-2032 5.1. Historical Market Volume ('000 Units) Analysis, 2017-2021 5.2. Current and Future Market Volume ('000 Units) Projections, 2022-2032 5.3. Y-o-Y Growth Trend Analysis 6. Global Metabolic Testing Market - Pricing Analysis 6.1. Pricing Analysis By Product 6.2. Global Average Pricing Analysis Benchmark 7. Global Metabolic Testing Market Demand (in Value or Technology in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032 7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Market Background 8.1. Global Cigar industry Outlook 8.1.1. Perception of Cigars 8.1.2. Prevalence of Smoking Cigars among Adults 8.1.3. Top 10 Cigars & Cigarillo Companies in the World 8.2. Macro-Economic Factors 8.2.1. GDP Growth Outlook 8.2.2. Consumer Spending Outlook 8.2.3. GDP Growth Rate Analysis 8.2.4. Income Group Population Overview 8.2.5. Per Capita Disposable Income 8.3. Forecast Factors - Relevance & Impact 8.3.1. Top Companies Historical Growth 8.3.2. Urbanization Growth Outlook 8.3.3. Others 8.4. PESTLE Analysis of Global Metabolic Testing Market 8.5. Investment Feasibility Matrix of Metabolic Testing Market 8.6. Porter’s Five Forces Analysis of Global Metabolic Testing Market 8.7. Market Dynamics 8.7.1. Drivers 8.7.2. Restraints 8.7.3. Opportunity Analysis 9. Global Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Product 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis by Product, 2017 - 2021 9.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Product, 2022 - 2032 9.3.1. CPET Systems 9.3.2. Metabolic Carts 9.3.3. Body Consumption Analyzers 9.3.4. ECGs/EKGs Attachable to CPET Systems 9.3.5. Software 9.4. Market Attractiveness Analysis by Product 10. Global Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Application 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis by Application, 2017 - 2021 10.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Application, 2022 - 2032 10.3.1. Lifestyle Diseases 10.3.2. Critical Care 10.3.3. Human Performance Testing 10.3.4. Dysmetabolic Syndrome X 10.3.5. Metabolic Disorders 10.3.6. Other Applications 10.4. Market Attractiveness Analysis by Application 11. Global Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Technology 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis by Technology, 2017 - 2021 11.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Technology, 2022 - 2032 11.3.1. VO2 Max Analysis 11.3.2. RMR Analysis 11.3.3. Body Composition Analysis 11.4. Market Attractiveness Analysis by Technology 12. Global Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032, by End User 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis by Flavor, 2017 - 2021 12.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Flavor, 2022 - 2032 12.3.1. Hospitals 12.3.2. Laboratories 12.3.3. Sports Training Centers 12.3.4. Gyms 12.3.5. Other End Users 12.4. Market Attractiveness Analysis by Flavor 13. Global Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Region 13.1. Introduction 13.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis by Region, 2017 - 2021 13.3. Current Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Region, 2022 - 2032 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. East Asia 13.3.5. South Asia 13.3.6. Oceania 13.3.7. Middle East and Africa (MEA) 13.4. Market Attractiveness Analysis by Region 14. North America Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021 14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032 14.4.1. By Country 14.4.1.1. U.S. 14.4.1.2. Canada 14.4.2. By Product 14.4.3. By End User 14.4.4. By Application 14.4.5. By Technology 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Product 14.5.3. By End User 14.5.4. By Application 14.5.5. By Technology 15. Latin America Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021 15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032 15.4.1. By Country 15.4.1.1. Brazil 15.4.1.2. Mexico 15.4.1.3. Rest of Latin America 15.4.2. By Product 15.4.3. By End User 15.4.4. By Application 15.4.5. By Technology 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Product 15.5.3. By End User 15.5.4. By Application 15.5.5. By Technology 16. Europe Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021 16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032 16.4.1. By Country 16.4.1.1. Germany 16.4.1.2. Italy 16.4.1.3. France 16.4.1.4. U.K. 16.4.1.5. Spain 16.4.1.6. Rest of Europe 16.4.2. By Product 16.4.3. By End User 16.4.4. By Application 16.4.5. By Technology 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Product 16.5.3. By End User 16.5.4. By Application 16.5.5. By Technology 17. South Asia Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032 17.1. Introduction 17.2. Pricing Analysis 17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021 17.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032 17.4.1. By Country 17.4.1.1. India 17.4.1.2. Thailand 17.4.1.3. Indonesia 17.4.1.4. Malaysia 17.4.1.5. Rest of South Asia 17.4.2. By Product 17.4.3. By End User 17.4.4. By Application 17.4.5. By Technology 17.5. Market Attractiveness Analysis 17.5.1. By Country 17.5.2. By Product 17.5.3. By End User 17.5.4. By Application 17.5.5. By Technology 18. East Asia Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032 18.1. Introduction 18.2. Pricing Analysis 18.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021 18.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032 18.4.1. By Country 18.4.1.1. China 18.4.1.2. Japan 18.4.1.3. South Korea 18.4.2. By Product 18.4.3. By End User 18.4.4. By Application 18.4.5. By Technology 18.5. Market Attractiveness Analysis 18.5.1. By Country 18.5.2. By Product 18.5.3. By End User 18.5.4. By Application 18.5.5. By Technology 19. Oceania Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032 19.1. Introduction 19.2. Pricing Analysis 19.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021 19.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032 19.4.1. By Country 19.4.1.1. Australia 19.4.1.2. New Zealand 19.4.2. By Product 19.4.3. By End User 19.4.4. By Application 19.4.5. By Technology 19.5. Market Attractiveness Analysis 19.5.1. By Country 19.5.2. By Product 19.5.3. By End User 19.5.4. By Application 19.5.5. By Technology 20. Middle East and Africa Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032 20.1. Introduction 20.2. Pricing Analysis 20.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021 20.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032 20.4.1. By Country 20.4.1.1. GCC Countries 20.4.1.2. Northern Africa 20.4.1.3. South Africa 20.4.1.4. Rest of Middle East and Africa 20.4.2. By Product 20.4.3. By End User 20.4.4. By Application 20.4.5. By Technology 20.5. Market Attractiveness Analysis 20.5.1. By Country 20.5.2. By Product 20.5.3. By End User 20.5.4. By Application 20.5.5. By Technology 21. Key Countries’ Metabolic Testing Market Analysis 2022-2032 21.1. Introduction 21.1.1. Market Value Proportion Analysis, By Key Countries 21.1.2. Global Vs. Country Growth Comparison 21.2. U.S. Metabolic Testing Market Analysis 21.2.1. By Product 21.2.2. By End User 21.2.3. By Application 21.2.4. By Technology 21.3. Canada Metabolic Testing Market Analysis 21.3.1. By Product 21.3.2. By End User 21.3.3. By Application 21.3.4. By Technology 21.4. Mexico Metabolic Testing Market Analysis 21.4.1. By Product 21.4.2. By End User 21.4.3. By Application 21.4.4. By Technology 21.5. Brazil Metabolic Testing Market Analysis 21.5.1. By Product 21.5.2. By End User 21.5.3. By Application 21.5.4. By Technology 21.6. Germany Metabolic Testing Market Analysis 21.6.1. By Product 21.6.2. By End User 21.6.3. By Application 21.6.4. By Technology 21.7. Italy Metabolic Testing Market Analysis 21.7.1. By Product 21.7.2. By End User 21.7.3. By Application 21.7.4. By Technology 21.8. U.K. Metabolic Testing Market Analysis 21.8.1. By Product 21.8.2. By End User 21.8.3. By Application 21.8.4. By Technology 21.9. China Metabolic Testing Market Analysis 21.9.1. By Product 21.9.2. By End User 21.9.3. By Application 21.9.4. By Technology 21.10. Japan Metabolic Testing Market Analysis 21.10.1. By Product 21.10.2. By End User 21.10.3. By Application 21.10.4. By Technology 21.11. S. Korea Metabolic Testing Market Analysis 21.11.1. By Product 21.11.2. By End User 21.11.3. By Application 21.11.4. By Technology 21.12. India Metabolic Testing Market Analysis 21.12.1. By Product 21.12.2. By End User 21.12.3. By Application 21.12.4. By Technology 21.13. Australia and New Zealand Metabolic Testing Market Analysis 21.13.1. By Product 21.13.2. By End User 21.13.3. By Application 21.13.4. By Technology 21.14. South Africa Metabolic Testing Market Analysis 21.14.1. By Product 21.14.2. By End User 21.14.3. By Application 21.14.4. By Technology 22. Market Structure Analysis 22.1. Market Analysis by Tier of Companies (Metabolic Testing) 22.2. Market Concentration 22.3. Market Share Analysis of Top Players 22.4. Market Presence Analysis 22.4.1. By Regional footprint of Players 22.4.2. Product foot print by Players 22.4.3. Channel Foot Print by Players 23. Competition Analysis 23.1. Competition Dashboard 23.2. Pricing Analysis by Competition 23.3. Competition Benchmarking 23.4. Competition Deep Dive 23.4.1. CareFusion Corporation 23.4.1.1. Overview 23.4.1.2. Product Portfolio 23.4.1.3. Profitability by Market Segments (Product/Channel/Region) 23.4.1.4. Sales Footprint 23.4.1.5. Strategy Overview 23.4.1.5.1. Marketing Strategy 23.4.1.5.2. Product Strategy 23.4.1.5.3. Channel Strategy 23.4.2. General Electric Company 23.4.2.1. Overview 23.4.2.2. Product Portfolio 23.4.2.3. Profitability by Market Segments (Product/Channel/Region) 23.4.2.4. Sales Footprint 23.4.2.5. Strategy Overview 23.4.2.5.1. Marketing Strategy 23.4.2.5.2. Product Strategy 23.4.2.5.3. Channel Strategy 23.4.3. Geratherm Medical AG 23.4.3.1. Overview 23.4.3.2. Product Portfolio 23.4.3.3. Profitability by Market Segments (Product/Channel/Region) 23.4.3.4. Sales Footprint 23.4.3.5. Strategy Overview 23.4.3.5.1. Marketing Strategy 23.4.3.5.2. Product Strategy 23.4.3.5.3. Channel Strategy 23.4.4. MGC Diagnostics Corporation 23.4.4.1. Overview 23.4.4.2. Product Portfolio 23.4.4.3. Profitability by Market Segments (Product/Channel/Region) 23.4.4.4. Sales Footprint 23.4.4.5. Strategy Overview 23.4.4.5.1. Marketing Strategy 23.4.4.5.2. Product Strategy 23.4.4.5.3. Channel Strategy 23.4.5. OSI Systems, Inc. 23.4.5.1. Overview 23.4.5.2. Product Portfolio 23.4.5.3. Profitability by Market Segments (Product/Channel/Region) 23.4.5.4. Sales Footprint 23.4.5.5. Strategy Overview 23.4.5.5.1. Marketing Strategy 23.4.5.5.2. Product Strategy 23.4.5.5.3. Channel Strategy 23.4.6. AEI Technologies, Inc. 23.4.6.1. Overview 23.4.6.2. Product Portfolio 23.4.6.3. Profitability by Market Segments (Product/Channel/Region) 23.4.6.4. Sales Footprint 23.4.6.5. Strategy Overview 23.4.6.5.1. Marketing Strategy 23.4.6.5.2. Product Strategy 23.4.6.5.3. Channel Strategy 23.4.7. Cortex Biophysik GmbH 23.4.7.1. Overview 23.4.7.2. Product Portfolio 23.4.7.3. Profitability by Market Segments (Product/Channel/Region) 23.4.7.4. Sales Footprint 23.4.7.5. Strategy Overview 23.4.7.5.1. Marketing Strategy 23.4.7.5.2. Product Strategy 23.4.7.5.3. Channel Strategy 23.4.8. COSMED 23.4.8.1. Overview 23.4.8.2. Product Portfolio 23.4.8.3. Profitability by Market Segments (Product/Channel/Region) 23.4.8.4. Sales Footprint 23.4.8.5. Strategy Overview 23.4.8.5.1. Marketing Strategy 23.4.8.5.2. Product Strategy 23.4.8.5.3. Channel Strategy 23.4.9. Korr Medical Technologies, Inc. 23.4.9.1. Overview 23.4.9.2. Product Portfolio 23.4.9.3. Profitability by Market Segments (Product/Channel/Region) 23.4.9.4. Sales Footprint 23.4.9.5. Strategy Overview 23.4.9.5.1. Marketing Strategy 23.4.9.5.2. Product Strategy 23.4.9.5.3. Channel Strategy 23.4.10. Microlife Medical Home Solutions, Inc. 23.4.10.1. Overview 23.4.10.2. Product Portfolio 23.4.10.3. Profitability by Market Segments (Product/Channel/Region) 23.4.10.4. Sales Footprint 23.4.10.5. Strategy Overview 23.4.10.5.1. Marketing Strategy 23.4.10.5.2. Product Strategy 23.4.10.5.3. Channel Strategy 23.4.11. Parvo Medics, Inc. 23.4.11.1. Overview 23.4.11.2. Product Portfolio 23.4.11.3. Profitability by Market Segments (Product/Channel/Region) 23.4.11.4. Sales Footprint 23.4.11.5. Strategy Overview 23.4.11.5.1. Marketing Strategy 23.4.11.5.2. Product Strategy 23.4.11.5.3. Channel Strategy 24. Assumptions and Acronyms Used 25. Research Methodology
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療機器）の最新刊レポート
Persistence Market Research社の医療・製薬・メディカルデバイス分野での最新刊レポート
本レポートと同じKEY WORD（led）の最新刊レポート
よくあるご質問Persistence Market Research社はどのような調査会社ですか?パーシスタンスマーケットリサーチ（Persistence Market Research/PMR）は独自の方法論を用いたデータ解析と市場調査をベースに広範な産業調査報告書とカスタム調査を提供しています... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |
